Blood. 2005 July 15; 106(2): 572–576. Role of molecular mimicry to HIV-1 peptides in HIV-1–related immunologic thrombocytopenia Zongdong Li, Michael A.

Slides:



Advertisements
Similar presentations
Lecture outline Types of hypersensitivity reactions
Advertisements

Idiopathic Thrombocytopenic Purpura
Complement Terry Kotrla, MS, MT(ASCP)BB Fall 2007.
Developing Immunotherapy for Autoimmune Diseases
» Surface Relations ˃Stomach ˃Renal ˃Colon » Suspended by ˃Phrenosplenic ligament ˃Gastrosplenic ligament ˃Splenocolic ligament ˃Gastrocolic ligament.
Dengue virus Huan-Yao Lei, Ph.D.
Manuscript summary Chronic Lymphoid Leukemia (CLL) Background Genetically engineering T cells Patient treatment history Engineered T cell therapy and.
Diagnostic Immunology Topic: Immunological Tolerance Objectives: Define Immunological tolerance Define Immunological tolerance Discuss mechanism of tolerance.
Ch. 43 The Immune System.
Hemostatic System - general information Normal hemostatic system –vessel wall –circulating blood platelets –blood coagulation and fibrynolysis Platelets.
Platelets and Metastasis In Mice and in Humans, Platelets are Important Mediators of Metastatic process Gabriel Gasic, Tatiana Gasic, Carleton Stewart.
High Affinity HIV-1 Specific CTL Become Exhausted in Early HIV-1 Infection High Affinity HIV-1 Specific CTL Become Exhausted in Early HIV-1 Infection Abstract.
ITP Immune (Idiopathic) Thrombocytopenic Purpura AM Report 5/25/2010.
Figure 43.0 Specialized lymphocytes attacking a cancer cell.
Immune System Disorders What is an allergy anyway?
Online Counseling Resource YCMOU ELearning Drive… School of Architecture, Science and Technology Yashwantrao Chavan Maharashtra Open University, Nashik.
THROMBOCYTOPENIA - reduced platelet count -. First of all.. what are platelets? Platelets: tiny cells that circulate in the blood and whose function is.
Autoimmune Idiopathic Thrombocytopenic Purpura (ITP) Nicola Davis.
Lecture 22 Autoimmunity.
Copyright © 2006 Pearson Education, Inc., publishing as Benjamin Cummings Chapter 14 Specific Immunity (adaptive immunity)
Engineering Antibodies (2) Immunotherapeutic Examples MSc Programme University of Nottingham 14 th February 2005 by Mike Clark, PhD Department of Pathology.
Antibody and B cell responses may control circulating lipopolysaccharide in patients with HIV infection Lim A 1, Amini A 1, D’Orsogna L 2, Rajasuriar R.
Gender differences in immune responses
Immunity. Koch’s Rules Identify pathogen (disease causing agent) Grow only the pathogen in a petri dish, no other organism After growth, the pathogen.
Antigens, Immunogens, Epitopes, and Haptens. Innate and adaptive immunity:
AUTOIMMUNITY. Self/Non-self Discrimination Autoimmunity is a problem of self/non-self discrimination.
THE COMPLEMENT SYSTEM. The complement system The complement system is a set of plasma proteins that act in a cascade to attack and kill extracellular.
Heavy Chains – Isotypic Differences
Immunology. Purpose of the immune system: –Discriminate self from non-self Non-self –Antigens Immunity: –All mechanisms used by the host to protect itself.
___________DEFENSES of the HOST: THE IMMUNE RESPONSE
THE IMMUNE RESPONSES TO VIRUSES
Immunology B cells and Antibodies – humoral
The complement system is a biochemical cascade that helps, or “complements”, the ability of antibodies to clear pathogens from an organism. It is part.
Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura Journal.
The pathogenesis of immune thrombocytopaenic purpura Nichola Cooper and James Bussel Department of Pediatrics, Weill Medical College of Cornell University,
Date of download: 7/8/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Effector mechanisms by which drugs mediate a positive direct antiglobulin.
Intravenous Immunoglobulin
GENERAL IMMUNOLOGY PHT 324
GENERAL IMMUNOLOGY PHT 324
Chapter 7 The Complement System Dr. Capers
Effector mechanisms by which drugs mediate a positive direct antiglobulin test. Relationships of drug, antibody-combining site, and red blood cell membrane.
Autoimmune diseases Ch. 4 p (99 – 159) March 7 /2016 March
Immunoglobulins structure and classification
Autoimmune Diseases Autoimmune Diseases Presented By Dr. Manal Yassin.
Antibodies (Immunoglobulin)
Immunodeficiency (2 of 2)
Chapter 6 The Complement System
B lymphocyte Clonal Selection Process Plasma Cells.
AUTOIMMUNE DISEASES.
by Kesheng Dai, Richard Bodnar, Michael C. Berndt, and Xiaoping Du
Complement-Independent, Peroxide-Induced Antibody Lysis of Platelets in HIV-1- Related Immune Thrombocytopenia  Michael Nardi, Stephen Tomlinson, M.Alba.
Cytotoxic Hypersensitivity (Type II)
Humoral & Cell-mediated immunity
A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor.
Figure 43.0 Specialized lymphocytes attacking a cancer cell
by Robert McMillan, Jennifer Lopez-Dee, and Joseph C. Loftus
Nat. Rev. Rheumatol. doi: /nrrheum
Platelet satellitism as a cause of spurious thrombocytopenia
RESISTANCE OF THE BODY TO INFECTION
Pathogenic Roles of B Cells in Human Autoimmunity
Immune thrombocytopenic purpura (ITP)
Immunodeficiency (2 of 2)
The pathophysiology of anaphylaxis
References Kuby Immunology 7th Edition 2013 Chapter 16 Pages Pages
The identification and management of heparin-induced thrombocytopenia in the vascular patient  Glenn M. LaMuraglia, MD, Rabih Houbballah, MD, Michael.
Terry Kotrla, MS, MT(ASCP)BB
Ricardo U. Sorensen, MD, Luke A. Wall, MD 
Autoimmunity Immunology.
Lec.10 Immune response كلية المأمون الجامعة\قسم تقنيات التحليلات المرضية مادةالمناعة-النظري/المرحلةالثالثة م.م.رشد اياد عبدالحميد.
Role of TACI during infection.
Presentation transcript:

Blood July 15; 106(2): 572–576. Role of molecular mimicry to HIV-1 peptides in HIV-1–related immunologic thrombocytopenia Zongdong Li, Michael A. Nardi, and Simon Karpatkin (…) Patients with early HIV-1 infection commonly develop an immunologic thrombocytopenia (HIV-1-ITP) 1 with shortened platelet survival. 2 Early onset HIV-1-ITP is clinically indistinguishable from classic autoimmune idiopathic thrombocytopenia (AITP) and responsive to the same therapeutic agents used to treat AITP. 1,3-6 However, HIV-1-ITP is different from AITP with respect to markedly elevated platelet-associated IgG, IgM, C 3, and C 4 and the presence of serum circulating immune complexes (CICs) composed of the same. 3,4 These CICs also contain specific high-affinity IgG1 antibody (Ab) against the platelet glycoprotein IIIa (GPIIIa) integrin, 7 its anti-idiotype blocking Ab, 8 and platelet fragments. 9 Unlike classic AITP in which multiple Abs have been described with different specificities for platelet GPIIb, GPIIIa, and GPIb, 6 patients with HIV-1-ITP have an IgG1 Ab against an immunodominant epitope, GPIIIa49-66 (CAPESIEFPVSEAREVLED). This Ab induces thrombocytopenia in mice (mouse GPIIIa has 83% sequence similarity with human GPIIIa and macrophages with Fc receptors capable of clearing human IgG1) and correlates inversely with platelet count in HIV-1-ITP patients (r =–0.71). 7, Morris L, Distenfeld A, Amorosi E, Karpatkin S. Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med. 1982;96: []. 2. Najean Y, Rain JD. The mechanism of thrombocytopenia in patients with HIV infection. J Lab Clin Med. 1994;123: []. 3. Walsh C, Nardi M, Karpatkin S. On the mechanism of thrombocytopenic purpura in sexually-active homosexual men. N Engl J Med. 1984;311: []. 4. Savona S, Nardi M, Karpatkin S. Thrombocytopenic purpura in narcotics addicts. Ann Intern Med. 1985;102: []. 5. Ratnoff O, Menitove J, Aster R, Lederman M. Coincident classic hemophilia and “idiopathic” thrombocytopenic purpura in patients under treatment with concentrates of anti-hemophilic factor (factor VIII). N Engl J Med. 1983;308: []. 6. Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet. 1997;349: []. 7. Karpatkin S, Nardi M, Hymes K. Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor-immune complexes of human immunodeficiency virus 1 thrombocytopenic patients. Proc Natl Acad Sci U S A. 1995;92: []. 8. Nardi M, Karpatkin S. Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients. J Exp Med. 2000;191: []. 9. Nardi M, Tomlinson S, Greco M, Karpatkin S. Complement-independent, peroxide induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell. 2001;106: []. 10. Nardi MA, Liu LX, Karpatkin S. GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia. Proc Natl Acad Sci U S A. 1997;94: [].